NCT00437372 2025-05-02
Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Thomas Jefferson University
Phase 1 Completed
Thomas Jefferson University
University of Wisconsin, Madison
Washington University School of Medicine
Pfizer
Pfizer